Search results
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 4 hours agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Wealthspan Partners LLC Raises Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoWealthspan Partners LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities and ...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 5 days agoThe study also met its key secondary endpoints, with 37% of patients in the Rinvoq arm achieving...
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...
NBC 17 Raleigh· 6 days ago− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen ...
Amgen Inc. (NASDAQ:AMGN) Short Interest Update
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 10,470,000 shares, a decline ...
Galapagos (NASDAQ:GLPG) Reaches New 52-Week Low at $29.45
ETF DAILY NEWS· 6 days agoShares of Galapagos NV (NASDAQ:GLPG – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $29.45 and last traded at $29.49, with a volume of 16106 shares. The ...
Bristol-Myers Squibb (NYSE:BMY) Short Interest Down 5.7% in March
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 35,120,000 shares, a decline of 5.7% ...
Clarus Group Inc. Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoClarus Group Inc. trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 39.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & ...
FY2024 EPS Estimates for Bristol-Myers Squibb (NYSE:BMY) Reduced by William Blair
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a research note issued to ...